Find doctoral opportunities

University of Glasgow · College of Medical, Veterinary & Life Sciences; School of Cardiovascular & Metabolic Health and School of Chemistry; MVLS/EPSRC doctoral training programme · United Kingdom

PhD in Drug Discovery: Investigating PROTAC-Mediated Phospholamban Degradation for Heart Failure Target Validation

MVLS/EPSRC doctoral training programme, 3.5 years. Glasgow states that tuition fees and a stipend of at least £21,805 (the 2026/27 UKRI minimum) are provided for all students; laboratory expenses are covered. For international applicants, the page does not quantify whether this means the full international fee or the fee-gap top-up. The 2027/28 stipend and fee figures are not yet confirmed. Visa and NHS surcharge are separate; Glasgow estimates approximately £5,000–£6,000 across the PhD. The published 2027/28 international non-clinical research fee of £33,708/year is not itself a promise of fee coverage; possible bench fees require confirmation.

Read full funding details

MVLS/EPSRC doctoral training programme, 3.5 years. Glasgow states that tuition fees and a stipend of at least £21,805 (the 2026/27 UKRI minimum) are provided for all students; laboratory expenses are covered. For international applicants, the page does not quantify whether this means the full international fee or the fee-gap top-up. The 2027/28 stipend and fee figures are not yet confirmed. Visa and NHS surcharge are separate; Glasgow estimates approximately £5,000–£6,000 across the PhD. The published 2027/28 international non-clinical research fee of £33,708/year is not itself a promise of fee coverage; possible bench fees require confirmation.

• heart failure
• PROTAC
• phospholamban